Pre-market hot trades in US stocks: AIOS Tech up 12.08% in pre-market; Credo Tech down 5.42% in pre-market

Pre-market Hot Trades in US Stocks AIOS Tech, up 12.08% in pre-market trading, has no significant news recently. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Credo Tech is down 5.42% in pre-market trading. There is no significant news recently; trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no_news Top Gainers in Pre-market US Stocks Calidi Biotherapeutics, up 44.13% in pre-market trading, has no significant news recently. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Direct Digital, up 40.15% in pre-market trading, has no significant news recently. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Bed Bath & Beyond is up 26.03% in pre-market trading. Based on recent key news: On April 28, Bed Bath & Beyond announced its first-quarter earnings report, with net sales increasing by 6.9% to $248 million, exceeding market expectations of $240 million. The adjusted loss per share was 25 cents, narrowing from 42 cents in the same period last year. Following the earnings report, the company's stock price rose 26.03% in pre-market trading. On April 27, Bed Bath & Beyond announced the appointment of Kyla Robinson to lead the technological transformation aimed at enhancing the customer experience and operational efficiency of the "Everything Home" platform. This move is seen by the market as a positive signal for the company's restructuring and strategic adjustments, driving the stock price up. On April 28, Jefferies analysts stated that although Bed Bath & Beyond shows early signs of recovery, its acquisition-driven strategy carries execution risks that limit short-term upside potential. The analysts' cautious stance has had some impact on the stock price. The overall industry is performing well, and macroeconomic data supports consumer goods demand